We collected information about Aastrom Biosciences Inc Hours for you. Follow the liks to find out everything about Aastrom Biosciences Inc Hours.
https://www.sec.gov/Archives/edgar/data/887359/000093639207000771/a33915ddef14a.htm
The accompanying proxy is solicited by the Board of Directors of Aastrom Biosciences, Inc., a Michigan corporation, for use at the Annual Meeting of Shareholders to be held November 7, 2007, or any adjournment thereof, for the purposes set forth in the accompanying Notice of Annual Meeting. The date of this Proxy Statement is October 11, 2007 ...
https://www.marketscreener.com/quote/stock/AASTROM-BIOSCIENCES-INC-14591271/
AASTROM BIOSCIENCES INC. Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the ...
https://www.glassdoor.com/Overview/Working-at-Aastrom-Biosciences-EI_IE6539.11,30.htm
Revenue: $50 to $100 million (USD) Competitors: UNKNOWN. Aastrom Biosciences brings new life to dying tissue. The development-stage company's proprietary tissue repair technology uses a patient's own cells (harvested from bone marrow) to manufacture treatments for a number of chronic diseases. The new cells, created through a sterile, ...
https://www.marketscreener.com/quote/stock/AASTROM-BIOSCIENCES-INC-14591271/company/
AASTROM BIOSCIENCES INC : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | Nasdaq
https://finance.yahoo.com/news/aastrom-biosciences-changes-name-vericel-222000674.html
Aastrom Biosciences, Inc. , a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the change of its corporate ...
https://www.sec.gov/Archives/edgar/data/887359/000095010901503540/d10k.htm
Aastrom Biosciences, Inc. is a leader in the development of human cell therapy products intended for a broad range of medical applications based on its patented process and device capabilities. Our lead cell therapeutic products under development include Dendricell ™ products (DC-I and DCV-I) for the clinical-scale production of dendritic ...
https://stemcellres.biomedcentral.com/articles/10.1186/scrt117
Aastrom Biosciences has developed a proprietary cell-processing technology that enables the manufacture of ixmyelocel-T, a patient-specific multicellular therapy expanded from a small sample of a patient's own bone marrow. Ixmyelocel-T is produced under current good manufacturing practices (cGMP) in a fully closed, automated system that expands …
https://contracts.onecle.com/aastrom/loyola-trial-1996-08-28.shtml
CLINICAL TRIAL AGREEMENT ----- This Clinical Trial Agreement ("Agreement") is entered into as of the 28 day of August, 1996 (the "Effective Date"), by and among Aastrom Biosciences, Inc. ("Aastrom"), located at 24 Frank Lloyd Wright Dr., Lobby L, Ann Arbor, MI 48105, and Loyola University Medical Center Cancer Center (the "Institution"), located at 2160 South …
https://investors.vcel.com/news-releases/news-release-details/aastrom-announces-definitive-agreement-acquire-sanofis-cell
ANN ARBOR, Mich., April 21, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has entered into a definitive agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) …
https://seekingalpha.com/article/2225683-deal-to-acquire-sanofis-ctrm-could-double-shares-of-aastrom-biosciences
On May 15, 2014, Aastrom Biosciences, Inc. (ASTM) reported financial results for the first quarter ended March 31, 2014. The company did not report meaningful revenues in …
Searching for Aastrom Biosciences Inc Hours?
You can just click the links above. The info is collected for you.
